← All companies

RLAY

Relay Therapeutics, Inc.

RLAY Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$18.78

-0.67 -3.44%

Key statistics

from XBRL data in SEC filings

Market cap

$3.60B

Revenue (TTM)

$10.7M

Net income (TTM)

-$273M

EPS (TTM)

$-1.56

P/E ratio

—

Dividend yield

—

Free cash flow

-$236M

Cash

$205M

Total assets

$700M

Gross margin

—

52-week range

$3.03 – $20.79

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Amended charter or bylaws; Shareholder vote results Jun 9, 2026 8-K Entered a material agreement May 21, 2026 8-K Regulation FD disclosure; Other events May 19, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 8-K Regulation FD disclosure; Other events Apr 27, 2026 8-K Regulation FD disclosure; Other events Mar 16, 2026 8-K Amended charter or bylaws Mar 11, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Regulation FD disclosure; Other events Feb 3, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Director or officer change Jun 11, 2025 8-K Shareholder vote results Jun 6, 2025 8-K Entered a material agreement; Terminated a material agreement Jun 4, 2025 10-Q Quarter ended 2025-03-31 May 5, 2025 8-K Results of operations (earnings release) May 5, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Results of operations (earnings release) Feb 26, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Regulation FD disclosure; Other events Dec 11, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Entered a material agreement; Other events Sep 11, 2024 8-K Regulation FD disclosure; Other events Sep 9, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Terminated a material agreement Jul 16, 2024 8-K Regulation FD disclosure; Other events Jun 6, 2024 8-K Shareholder vote results Jun 3, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Results of operations (earnings release) May 2, 2024 10-K Fiscal year ended 2023-12-31 Feb 22, 2024 8-K Results of operations (earnings release) Feb 22, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Jan 8, 2024 10-Q Quarter ended 2023-09-30 Nov 2, 2023 8-K Results of operations (earnings release) Nov 2, 2023